Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

NCT01715350 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: PM012
DRUG: Placebo

Sponsor

VTBIO Co. LTD

Collaborators

[object Object]